UK-based pharmaceutical company GSK has announced positive headline data from the EAGLE-1 Phase III clinical trial of gepotidacin. Gepotidacin is an oral bactericidal antibiotic designed to treat ...
GSK has unveiled the data for its novel antibiotic gepotidacin as a treatment for gonorrhoea, putting the drug on track to become an important therapy for people with resistant forms of the ...
(Alliance News) - GSK PLC on Wednesday announced that the US Food & Drug Administration has accepted its New Drug Application for gepotidacin. The London-based biopharma company said the FDA has ...